Skip to main content

Currently Skimming:

1 Introduction
Pages 1-4

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... . In response, funders, publishers, and other key stakeholders have recognized the need to encourage and enhance transparent reporting of preclinical research findings across the biomedical research life cycle (e.g., Kiley et al., 2017; McNutt, 2014; Nosek et al., 1 This workshop was organized by an independent planning committee whose role was limited to identification of topics and speakers.
From page 2...
... The agenda for the workshop, titled Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting, was developed by an independent planning committee; the workshop Statement of Task is available in Box 1-1.7 The workshop was convened jointly by the Forum on Drug Discovery, Development, and Translation; the Forum on Neuroscience and Nervous System Disorders; the National Cancer Policy Forum; and the Roundtable on Genomics and Precision Health, and was sponsored by the Cell Press, The Lancet, the National Institutes of Health, and Nature Research. This workshop builds on recent consensus reports by the National Academies, including Reproducibility and Replicability in Science (NASEM, 2019, discussed further in Chapter 2)
From page 3...
... Workshop objectives: • Highlight current efforts by researchers, institutions, funders, and jour nals to increase transparency in proposing and reporting preclinical biomedical research; • Discuss journal and funder assessments of researchers' adherence to reporting guidelines, including a discussion of the effectiveness of checklists; •  onsider lessons learned from field-specific best practices for increased C transparency in reporting rigor elements (research design, methodology, analysis, interpretation, reporting of results) that are generalizable across biomedical research domains; • Discuss opportunities for improving the consistency of reporting guide lines and requirements for rigor and transparency by journals, funders, and institutions across the biomedical research life cycle; and • Consider approaches to compare reporting of rigor elements proposed in grant applications to those included in publications.
From page 4...
... . In the third panel session, speakers explored the practical application and effectiveness of checklists and guidelines for enhancing transparent reporting of biomedical research (Chapter 5)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.